Compare CEG & PFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CEG | PFE |
|---|---|---|
| Founded | 1999 | 1849 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 98.2B | 147.6B |
| IPO Year | 2021 | 2013 |
| Metric | CEG | PFE |
|---|---|---|
| Price | $269.16 | $26.69 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 14 |
| Target Price | ★ $384.53 | $29.29 |
| AVG Volume (30 Days) | 2.7M | ★ 30.4M |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | 0.57% | ★ 6.55% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 5.88 | 0.43 |
| Revenue | $25,533,000,000.00 | ★ $62,579,000,000.00 |
| Revenue This Year | $19.75 | N/A |
| Revenue Next Year | $7.73 | N/A |
| P/E Ratio | ★ $58.15 | $60.91 |
| Revenue Growth | ★ 8.34 | N/A |
| 52 Week Low | $228.63 | $23.59 |
| 52 Week High | $412.58 | $28.75 |
| Indicator | CEG | PFE |
|---|---|---|
| Relative Strength Index (RSI) | 48.65 | 66.18 |
| Support Level | $259.00 | $24.98 |
| Resistance Level | $266.00 | $26.60 |
| Average True Range (ATR) | 10.12 | 0.46 |
| MACD | 0.32 | 0.16 |
| Stochastic Oscillator | 34.08 | 99.43 |
Constellation Energy Corp producer of carbon-free energy and a supplier of energy products and services. The company offers generating capacity that includes nuclear, wind, solar, natural gas, and hydroelectric assets. It sells electricity, natural gas, and other energy-related products and sustainable solutions to various types of customers, including distribution utilities, municipalities, cooperatives, and commercial, industrial, public sector, and residential customers in markets across multiple geographic regions. Its operating segments and reporting units are Mid-Atlantic, Midwest, New York, ERCOT, and Other Power Regions.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.